Pregnancy increases the risk of injury associated with mental illness.
The varieties of malnutrition, substance abuse, and aggression that m
ay accompany mental illness can injure the unborn child in more severe
ways than the patient herself. Dangers associated with illness-relate
d behavior can outweight the risks of pharmacotherapy, but no psychotr
opic drug is approved for use during pregnancy. Failure to produce a p
rompt or lasting remission of psychiatric symptoms also is a significa
nt possibility with medication. The morbidity from continued illness a
nd the incompletely described adverse effects of psychotropic drugs in
creases the attractiveness of ECT for severely depressed pregnant pati
ents, especially with associated high-risk conditions. This paper disc
usses physiologic changes occurring during pregnancy and ECT and revie
ws contemporary monitors of maternal and fetal well-being. Guidelines
are suggested for ECT during regular and high-risk pregnancies. The au
thors conclude that using additional precautions with high-risk pregna
nt patients permits ECT to be given with relative safety; medical and
obstetric risk factors need not prevent its use.